Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Feb;64(2):227–230. doi: 10.1136/jnnp.64.2.227

Meta-analysis of the ACE gene in ischaemic stroke

P Sharma 1
PMCID: PMC2169971  PMID: 9489536

Abstract

OBJECTIVES—The angiotensin-1 converting enzyme (ACE) gene is known to have two polymorphic alleles I/D. People with the DD genotype have been shown to be at greater risk of myocardial infarction, but only in some studies. Similar studies in stroke patients also show inconsistent results, but most of these studies have been underpowered to detect a small contribution to stroke risk from the ACE gene. A meta-analysis was undertaken using all known publications of the ACE polymorphism in ischaemic stroke.
METHODS—Two computerised databases were searched for all publications relating to case-control studies using the ACE I/D variant in human ischaemic stroke. Seven association studies were identified and a meta-analysis was conducted using the Mantel-Haenszel estimate for odds ratio (OR) to determine whether the DD genotype predicted outcome in either a genetically dominant or recessive model.
RESULTS—1918 white subjects (1196 cases and 722 controls) were used in the meta-analysis. There was no difference in ACE genotype (χ2=2.92, p>0.05) or I/D allele frequency (χ2=3.28, p>0.05) in cases or controls. The overall OR for the D allele as an independent risk factor in ischaemic stroke was 1.31(95% confidence interval (95% CI): 1.06-1.62, p=0.01) under a recessive model, and 1.14 (95% CI: 0.91-1.44, p=0.26) under a dominant model.
CONCLUSIONS—This meta-analysis shows that the the D allele, acting recessively, is a modest but independent risk factor for ischaemic stroke onset. Meta-analysis may usefully be employed in allelic association studies for detecting small attributable risks of candidate genes in polygenic disorders.



Full Text

The Full Text of this article is available as a PDF (118.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  2. Catto A., Carter A. M., Barrett J. H., Stickland M., Bamford J., Davies J. A., Grant P. J. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke. 1996 Mar;27(3):435–440. [PubMed] [Google Scholar]
  3. Johanning G. L., Johnston K. E., Tamura T., Goldenberg R. L. Ethnic differences in angiotensin converting enzyme gene polymorphism. J Hypertens. 1995 Jun;13(6):710–711. doi: 10.1097/00004872-199506000-00021. [DOI] [PubMed] [Google Scholar]
  4. Kario K., Kanai N., Saito K., Nago N., Matsuo T., Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 1996 May 1;93(9):1630–1633. doi: 10.1161/01.cir.93.9.1630. [DOI] [PubMed] [Google Scholar]
  5. Lindpaintner K., Pfeffer M. A., Kreutz R., Stampfer M. J., Grodstein F., LaMotte F., Buring J., Hennekens C. H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995 Mar 16;332(11):706–711. doi: 10.1056/NEJM199503163321103. [DOI] [PubMed] [Google Scholar]
  6. Maeda Y., Ikeda U., Ebata H., Hojo Y., Seino Y., Hayashi Y., Kuroki S., Shimada K. Angiotensin-converting enzyme gene polymorphism in hypertensive individuals with parental history of stroke. Stroke. 1996 Sep;27(9):1521–1523. doi: 10.1161/01.str.27.9.1521. [DOI] [PubMed] [Google Scholar]
  7. Margaglione M., Celentano E., Grandone E., Vecchione G., Cappucci G., Giuliani N., Colaizzo D., Panico S., Mancini F. P., Di Minno G. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):304–309. doi: 10.1161/01.atv.16.2.304. [DOI] [PubMed] [Google Scholar]
  8. Markus H. S., Barley J., Lunt R., Bland J. M., Jeffery S., Carter N. D., Brown M. M. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke. 1995 Aug;26(8):1329–1333. doi: 10.1161/01.str.26.8.1329. [DOI] [PubMed] [Google Scholar]
  9. Morise T., Takeuchi Y., Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet. 1994 Jan 8;343(8889):125–125. doi: 10.1016/s0140-6736(94)90859-1. [DOI] [PubMed] [Google Scholar]
  10. Morishita R., Gibbons G. H., Ellison K. E., Lee W., Zhang L., Yu H., Kaneda Y., Ogihara T., Dzau V. J. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994 Sep;94(3):978–984. doi: 10.1172/JCI117464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Odawara M., Sasaki K., Yamashita K. Beta 3-adrenergic receptor gene variant and Japanese NIDDM: a pitfall in meta-analysis. Lancet. 1996 Sep 28;348(9031):896–897. doi: 10.1016/S0140-6736(05)64773-3. [DOI] [PubMed] [Google Scholar]
  12. Pitt B. Angiotensin-converting enzyme inhibitors in patients with coronary atherosclerosis. Am Heart J. 1994 Dec;128(6 Pt 2):1328–1332. doi: 10.1016/0002-8703(94)90255-0. [DOI] [PubMed] [Google Scholar]
  13. Prins J. M., Büller H. R. Meta-analysis: the final answer, or even more confusion? Lancet. 1996 Jul 20;348(9021):199–199. doi: 10.1016/s0140-6736(05)66148-x. [DOI] [PubMed] [Google Scholar]
  14. Pullicino P., Kwen P. L., Greenberg S., Becker A. L., Glenister N. Angiotensin-converting enzyme gene and lacunar stroke. Stroke. 1996 Mar;27(3):569–570. [PubMed] [Google Scholar]
  15. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343–1346. doi: 10.1172/JCI114844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Samani N. J., Thompson J. R., O'Toole L., Channer K., Woods K. L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996 Aug 15;94(4):708–712. doi: 10.1161/01.cir.94.4.708. [DOI] [PubMed] [Google Scholar]
  17. Sharma P., Carter N. D., Barley J., Brown M. M. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens. 1994 Aug;8(8):645–648. [PubMed] [Google Scholar]
  18. Sharma P., Carter N. D., Barley J., Lunt R., Seymour C. A., Brown M. M. Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction. J Hum Hypertens. 1994 Aug;8(8):633–634. [PubMed] [Google Scholar]
  19. Sharma P. Genes for ischaemic stroke: strategies for their detection. J Hypertens. 1996 Mar;14(3):277–285. doi: 10.1097/00004872-199603000-00002. [DOI] [PubMed] [Google Scholar]
  20. Sharma P. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 1997 Jan 7;95(1):281–284. [PubMed] [Google Scholar]
  21. Sharma P., Smith I., Maguire G., Stewart S., Shneerson J., Brown M. J. Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet. 1997 May 31;349(9065):1602–1603. doi: 10.1016/S0140-6736(05)61631-5. [DOI] [PubMed] [Google Scholar]
  22. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992 Jul;51(1):197–205. [PMC free article] [PubMed] [Google Scholar]
  23. Ueda S., Weir C. J., Inglis G. C., Murray G. D., Muir K. W., Lees K. R. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens. 1995 Dec;13(12 Pt 2):1597–1601. [PubMed] [Google Scholar]
  24. Zee R. Y., Lou Y. K., Griffiths L. R., Morris B. J. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992 Apr 15;184(1):9–15. doi: 10.1016/0006-291x(92)91150-o. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES